You have full text access to this OnlineOpen article

Endemic Fungal Infections in Solid Organ Transplant Recipients

L. Proia^1,*,
R. Miller²,
the AST Infectious Diseases Community of Practice¹

Article first published online: 16 DEC 2009

DOI: 10.1111/j.1600-6143.2009.02912.x

Issue

American Journal of Transplantation

Special Issue: AST Infectious Diseases Guidelines 2^nd Edition

Volume 9, Issue Supplement s4, pages S199–S207, December 2009

Additional Information

How to Cite

Proia, L., Miller, R. and the AST Infectious Diseases Community of Practice (2009), Endemic Fungal Infections in Solid Organ Transplant Recipients. American Journal of Transplantation, 9: S199–S207. doi: 10.1111/j.1600-6143.2009.02912.x

Author Information

¹
Section of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center Chicago, IL
²
Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City, IA

^* * Corresponding author: Laurie Proia, Laurie_A_Proia@rush.edu

Publication History

Issue published online: 16 DEC 2009
Article first published online: 16 DEC 2009

ARTICLE TOOLS

View Full Article (HTML) Get PDF (107K)

References

1
Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transplant Infect Dis 2007; 9: 310–317.
Direct Link:
2
Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transplant Infect Dis 2005; 7: 109–115.
Direct Link:
3
Pappas PG, Alexander B, Marr K. Invasive fungal infections (IFIs) in hematopoietic stem cell (HSCTs) and organ transplant recipients (OTRs): Overview of the TRANSNET database [abstract 671]. In: Programs and abstracts of the 42^nd Annual Meeting of the Infectious Diseases Society of America (Boston). Alexandria , VA : Infectious Diseases Society of America 2004; 174.
4
Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin N Am 2003; 17: 113–134.
5
Dworkin MS, Duckro AN, Proia L, Semel JD, Huhn G. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005; 41: e107–e111.
6
Sarosi GA, Davies SF. Blastomycosis: State of the art. Am Rev Respir Dis 1979; 120: 911–938.
7
Crampton TL, Light RB, Berg GM et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba Hospitals. Clin Infect Dis 2002; 34: 1310–1316.
8
Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72: 311–325.
9
Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: Report of a case and review. Clin Infect Dis 1993; 16: 54–58.
10
Gray NA, Baddour LM. Cutaneous inoculation blastomycosis. Clin Infect Dis 2002; 34: E44–E49.
11
Bradsher RW, Jr. Pulmonary blastomycosis. Semin Respir Crit Care Med 2008; 29: 174–181.
12
Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. New Engl J Med 1993; 329: 1231–1236.
13
Pappas PG, Pottage JC, Pottage JC, Powderly WG, Fraser VJ, Stratton CW et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Inter Med 1992; 116: 847–853.
14
Wheat J, Wheat H, Connolly P, Kleiman M, Supparatpinyo K, Nelson K et al. Cross-Reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997; 24: 1169–1171.
15
Durkin M, Witt J, LeMonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42: 4873–4875.
16
Chapman SW, Dismukes WE, Proia LA et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 1801–1812.
17
Pappas PG, Bradsher RW, Chapman SW et al. Treatment of blastomycosis with fluconazole: A pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1995; 20: 267–271.
18
Li RK, Ciblak MA, Nordoff N, Pasarell L, Warnock DW, McGinnis MR. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, coccidioides immitis, and histoplasma capsulatum. Antimicrob Agents Chemother 2000; 44: 1734–1736.
19
Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2956.
20
Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: Comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother 2003; 47: 1376–1381.
21
Parish JM, Blair JE. Coccidioidomycosis. Mayo Clin Proc 2008; 83: 343–349.
22
Galgiani JN. Coccidioidomycosis: A regional disease of national importance: Rethinking approaches for control. Ann Inter Med 1999; 130: 293–300.
23
Desai SA, Minai OA, Gordon SM, O’Neil B, Wiedemann HP, Arroliga AC. Coccidioidomycosis in non-endemic areas: A case series. Respir Med 2001; 95: 305–309.
24
Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94: 73–84.
25
Stevens DA. Coccidioidomycosis. New Engl J Med 1995; 332: 1077–1082.
26
Hirschmann JV. The Early History of Coccidioidomycosis: 1892–1945. Clin Infect Dis 2007; 44: 1202–1207.
27
Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Inter Med 1982; 142: 489–494.
28
Hall KA, Sethi GK, Rosado LJ, Martinez JD, Huston CL, Copeland JG. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993; 12: 525–526.
29
Holt CD, Winston DJ, Kubak B et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 1997; 24: 216–221.
30
Blair JE. Coccidioidomycosis in Patients Who Have Undergone Transplantation. Annals of the New York Academy of Sciences 2007; 1111 (Coccidioidomycosis Sixth International Symposium): 365–376.
31
Blair JE, Logan JL. Coccidoiodomycosis in solid organ transplantation. Clin Infect Dis 2001; 33:1536–1544.
32
Wright PW, Pappagianis D, Wilson M et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003; 37: 1265–1269.
33
Miller MB, Hendren R, Gilligan PH. posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004; 42: 2347–2349.
34
Valdivia L, Nix D, Wright M et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006; 12: 958–962.
35
Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006; 42: 103–107.
36
Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transplant Infect Dis 2003; 5: 3–8.
- CrossRef,
- PubMed,
- CAS
37
Durkin M, Connolly P, Kuberski T et al. Diagnosis of coccidioidomycosis with use of the coccidioides antigen enzyme immunoassay. Clin Infect Dis 2008; 47: e69-e73.
38
Galgiani JN, Ampel NM, Blair JE et al. Coccidioidomycosis. Clin Infect Dis 2005; 41: 1217–1223.
39
Galgiani JN, Catanzaro A, Cloud GA et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: A randomized, double-blind trial. Ann Inter Med 2000; 133: 676–686.
40
Proia LA, Tenorio AR. Successful use of voriconazole for treatment of coccidioides meningitis. Antimicrob Agents Chemother 2004; 48: 2341–2341.
41
Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 2005; 40: 1770–1776.
42
Antony S. Use of the Echinocandins (Caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 2004; 39: 879–880.
43
Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 2004; 54: 292–294.
44
Blair JE. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis 2008; 21: 415–420.
45
Cuellar-Rodriguez J, Avery RK, Lard M et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49: 710–716.
46
Botterel F, Romand S, Saliba F et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999; 18: 662–664.
47
Limaye AP, Connolly PA, Sagar M et al. Transmission of histoplasma capsulatum by organ transplantation. New Engl J Med 2000; 343: 1163–1166.
48
Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: Case report. Clin Infect Dis 1992; 14: 232–234.
49
Wheat LJ, Smith EJ, Sathapatayavongs B et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Inter Med 1983; 143: 703–707.
50
Ram Peddi V, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996; 10: 160–165.
- PubMed,
- Web of Science® Times Cited: 38
51
Davies SF, Sarosi GA, Peterson PK et al. Disseminated histoplasmosis in renal transplant recipients. Am J Surg 1979; 137: 686–691.
52
Doshi M, Katz D, Miller RA. Histoplasmosis among organ transplant recipeints: A nine year experience from an endemic region: Abstract# 1112. Am J Transplant 2006; 6: 441–442.
53
Hood AB, Inglis FG, Lowenstein L, Dossetor JB, MacLean LD. Histoplasmosis and thrombocytopenic purpura: Transmission by renal homotransplantation. Can Medl Assoc J 1965; 93: 587–592.
54
Dwyre DM, Bell AM, Siechen K, Sethi S, Raife TJ. Disseminated histoplasmosis presenting as thrombotic microangiopathy. Transfusion 2006; 46: 1221–1225.
Direct Link:
55
Odio CM, Navarrete M, Carrillo JM, Mora L, Carranza A. Disseminated histoplasmosis in infants. Pediatric Infectious Diseases J 1999; 18: 1065–1068.
56
Connolly PA, Durkin MM, LeMonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14: 1587–1591.
57
Wheat LJ. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther 2006; 6: 1207–1221.
58
Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, Brooks GF. Histoplasmosis in immunosuppressed patients. Am J Med 1978; 64: 923–932.
59
Kauffman CA. Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis 2008; 21: 421–425.
60
Wheat LJ, Freifeld AG, Kleiman MB et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 807–825.
61
Perfect JR. Treatment of non-aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 2005; 40(S6):401–408.
- CrossRef,
- Web of Science® Times Cited: 49
62
Dismukes WE, Bradsher RW, Cloud GC et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992; 93: 489–497.
63
Kohler S, Wheat LJ, Connolly P et al. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother 2000; 44: 1850–1854.
64
Zaoutis TE, Benjamin DK, Steinbach WJ. Antifungal treatment in pediatric patients. Drug Resistance Updates 2005; 8: 235–245.
65
Freifeld A, Proia LA, Andes D. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009; 53: 1648–1651.
66
Connolly P, Wheat LJ, Schnizlein-Bick C et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother 2000; 44: 2604–2608.
67
Restrepo A, Tobón A, Clark B et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007; 54: 319–327.
68
McKinsey DS, Kauffman CA, Pappas PG et al. Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1996; 23: 996–1001.
69
Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transplant Infect Dis 2002; 4: 148–151.
Direct Link:
70
Itraconazole package insert. In: janssen Pharmaceuticals, April 2008.
71
Saad AH, DePestel DD, Carver PL. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Pharmacotherapy 2006; 26: 1730–1744.
72
Sádaba B, Campanero MA, Quetglas EG, Azanza JR. Clinical relevance of sirolimus drug interactions in transplant patients. Transplant Proc 2005; 36: 3226–3228.
73
Barone JA, Koh JG, Bierman RH, Colaizzi JL, Swanson KA, Gaffar MC et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother 1993; 37: 778–784.
74
Stein AG, Daneshmend TK, Warnock DW, Bhaskar N, Burke J, Hawkey CJ. The effects of H2-receptor antagonists on the pharmacokinetics of itraconazole, a new oral antifungal. Br J Clin Pharmacol 1989; 27: 105–106.
75
Jaruratanasirikul S, Sriviriyajan S. Effect of omeprazole on the pharmacokinetics of itraconazole. Eur J Clin Pharmacol 1998; 54: 159–161.
76
Jaruratanasirikul S, Kleepkaew A. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 1997; 52: 235–237.
77
Barone JA, Moskovitz BL, Guarnieri J et al. Enhanced bioavailability of itraconazole in hydroxypropyl ß-cyclodextrin solution versus capsules in healthy volunteers. Antimicrob Agents Chemother 1998; 42: 1862–1865.
78
Poirier M, Cheymol G. Optimisation of itraconazole therapy using target drug concentrations. Clin Pharmacokinet 1998; 35: 461–473.

View Full Article (HTML) Get PDF (107K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Endemic Fungal Infections in Solid Organ Transplant Recipients

American Journal of Transplantation

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Endemic Fungal Infections in Solid Organ Transplant Recipients

American Journal of Transplantation

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this